• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Strategic Partners

640.00 DKK+4.92 %16.7. klo 17.59
Less than 1K followers

STRAP

NASDAQ Copenhagen

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+4.92 %
+14.29 %
-0.78 %
-9.86 %
-8.31 %
-44.59 %
-57.28 %
-98.15 %
-99.20 %

Strategic Partners is a Danish investment company. The company's business concept is to implement strategic partnerships with companies, where the company can take active ownership and create value. In addition to this, investments can also be made in other equity shares and properties to generate returns. Stategic Partners has its headquarters in Herlev.

Read more
Market cap
26.7M DKK
Turnover
9.81K DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
26.8.
2026

Interim report Q2'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release10.04.2025 klo 16.13

Selskabsmeddelelse 13 med vedhæftede fil

Strategic Partners
Regulatory press release25.02.2025 klo 09.44

Opdateret finanskalender 2025

Strategic Partners
Regulatory press release18.09.2024 klo 16.26

Business update - opdatering på identitetsændring:

Strategic Partners

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release14.05.2024 klo 11.55

Periodemeddelelse Første Kvartal 2024

Strategic Partners
Regulatory press release18.04.2024 klo 16.39

Referat Fra Ordinær Generalforsamling Den 18. April 2024 Kl. 15:00

Strategic Partners
Regulatory press release27.03.2024 klo 15.20

Indkaldelse Til Ordinær Generalforsamling Den 18. April 2024 Kl. 15:00

Strategic Partners
Regulatory press release27.03.2024 klo 14.50

Årsregnskab 2023 – Et begivenhedsrigt år for selskabet

Strategic Partners
Regulatory press release25.03.2024 klo 17.04

Foreløbige tal for 2023 og finansielle forventninger til 2024

Strategic Partners
Regulatory press release30.05.2023 klo 20.41

Change in management

Strategic Partners
Regulatory press release19.05.2023 klo 10.21

Major shareholder announcement

Strategic Partners
Regulatory press release17.05.2023 klo 19.51

Major shareholder announcement

Strategic Partners
Regulatory press release17.05.2023 klo 16.29

Resolutions passed at the Annual General Meeting

Strategic Partners
Regulatory press release17.05.2023 klo 13.44

Changes to the Board of Directors

Strategic Partners
Regulatory press release12.05.2023 klo 19.02

Major shareholder announcement

Strategic Partners
Regulatory press release09.05.2023 klo 11.45

Major shareholder announcement

Strategic Partners
Regulatory press release09.05.2023 klo 11.35

Major shareholder announcement

Strategic Partners
Regulatory press release25.04.2023 klo 23.27

Notice to convene Annual General Meeting

Strategic Partners
Regulatory press release25.04.2023 klo 23.20

Orphazyme Announces Publication of 2022 Financial Results and Annual Report

Strategic Partners
Regulatory press release17.04.2023 klo 09.52

Change to Financial Calendar for 2023 and update regarding class action lawsuit in United States

Strategic Partners
Regulatory press release26.09.2022 klo 18.25

Orphazyme reports financial results in Interim Report First Half 2022

Strategic Partners